Skip to main content

Table 2 Multivariate analysis of factors affecting exacerbation rate of esophageal varices after BRTO for gastric varices

From: Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices

Factors

Category

Univariate P value*

Multivariate

HR (95% CI)

P value**

Age (years)

 < 71 vs. ≥ 71

0.22

  

Sex

Male vs. Female

0.97

  

Etiology

HBV plus HCV vs. others

0.74

  

Albumin (g/dL)

 < 3.5 vs. ≥ 3.5

0.15

  

Total bilirubin (mg/dL)

 < 1.0 vs. ≥ 1.0

0.16

  

Prothrombin activity (%)

 < 81 vs. ≥ 81

0.97

  

Aspartate aminotransferase (IU/L)

 < 37 vs. ≥ 37

0.04

3.09 (1.01–9.47)

0.04

Alanine aminotransferase (IU/L)

 < 25 vs. ≥ 25

0.06

  

γ-Glutamyl transpeptidase (IU/L)

 < 64 vs. ≥ 64

0.10

  

Platelet count (× 103/µL)

 < 102 vs. ≥ 102

0.74

  

Ammonia (µg/dL)

 < 55 vs. ≥ 55

0.05

  

Child–Pugh class

A vs. B or C

0.26

  

Fib-4 index

 < 4.80 vs. ≥ 4.80

0.58

  

Presence of splenomegaly

Yes vs. no

0.58

  

Gastric varices bleeding

Yes vs. no

0.69

  

Co-existence of esophageal varices

Yes vs. no

0.50

  

History of hepatocellular carcinoma

Yes vs. no

0.88

  

Diameter of LGV before BRTO

 < 5 vs. ≥ 5

0.40

  

Liver stiffness measurement (kPa)

 < 30.2 vs. ≥ 30.2

0.01

  

Pre-HVPG (mmHg)

 < 13 vs. ≥ 13

0.06

  

Post-HVPG (mmHg)

 < 13 vs. ≥ 13

0.03

3.04 (1.25–7.38)

0.01

  1. HBV, hepatitis B virus; HCV, hepatitis C virus; LGV, left gastric vein; BRTO, balloon-occluded retrograde transvenous obliteration; HVPG, hepatic venous pressure gradient; Pre-HVPG, HVPG measured before BRTO; Post-HVPG, HVPG measured after BRTO; HR, hazard ratio; CI, confidence interval